Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases.
Gauckler P, Kesenheimer JS, Geetha D, Odler B, Eller K, Laboux T, Alberici F, Zappa M, Chebotareva N, Moiseev S, Bonilla M, Jhaveri KD, Oniszczuk J, Audard V, Costa D, Mastroianni-Kirsztajn G, Bruchfeld A, Muto M, Windpessl M, Mayer G, Kronbichler A. Gauckler P, et al. Among authors: alberici f. Front Immunol. 2023 Sep 12;14:1228457. doi: 10.3389/fimmu.2023.1228457. eCollection 2023. Front Immunol. 2023. PMID: 37767096 Free PMC article.
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy.
Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Piva S, Latronico N, Focà E, Castelli F, Gaggia P, Movilli E, Bove S, Malberti F, Farina M, Bracchi M, Costantino EM, Bossini N, Gaggiotti M, Scolari F; Brescia Renal COVID Task Force. Alberici F, et al. Kidney Int Rep. 2020 Apr 4;5(5):580-585. doi: 10.1016/j.ekir.2020.04.001. eCollection 2020 May. Kidney Int Rep. 2020. PMID: 32292866 Free PMC article. Review.
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Vivarelli M, Barratt J, Beck LH Jr, Fakhouri F, Gale DP, Goicoechea de Jorge E, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith RJH; for Conference Participants. Vivarelli M, et al. Kidney Int. 2024 Sep;106(3):369-391. doi: 10.1016/j.kint.2024.05.015. Epub 2024 Jun 4. Kidney Int. 2024. PMID: 38844295 Free article.
Clinical Significance of the Cystic Phenotype in Alport Syndrome.
Zeni L, Mescia F, Toso D, Dordoni C, Mazza C, Savoldi G, Econimo L, Cortinovis R, Fisogni S, Alberici F, Scolari F, Izzi C. Zeni L, et al. Among authors: alberici f. Am J Kidney Dis. 2024 Sep;84(3):320-328.e1. doi: 10.1053/j.ajkd.2024.02.005. Epub 2024 Mar 19. Am J Kidney Dis. 2024. PMID: 38514012 Free article.
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving.
Carta A, Tedesco M, Mescia F, Manenti C, Lucca B, Verzeletti F, Guerini A, Terni FG, Zubani R, Guerini S, Valzorio B, Jeannin G, Carli O, Camerini C, Possenti S, Gaggia P, Alberici F. Carta A, et al. Among authors: alberici f. Kidney Int Rep. 2023 Nov 15;9(2):482-485. doi: 10.1016/j.ekir.2023.11.009. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344732 Free PMC article. No abstract available.
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study.
Borrelli S, Garofalo C, Reboldi G, Coppola A, Chiodini P, Simeoni M, Mazzieri A, Della Volpe L, Gallieni M, Zummo C, Cottone S, Ravera M, Aucella F, Aucella F, Stallone G, Gismondi V, Alberici F, Gregori M, Castellano G, Vettoretti S, Cozzolino M, Ruotolo C, Minutolo R, De Nicola L. Borrelli S, et al. Among authors: alberici f. Clin Kidney J. 2024 Oct 17;17(11):sfae316. doi: 10.1093/ckj/sfae316. eCollection 2024 Nov. Clin Kidney J. 2024. PMID: 39502370 Free PMC article.
146 results